9 things to know about the J&J, AstraZeneca COVID-19 vaccines & blood clots

Reports of a rare type of blood clot following vaccination with both Johnson & Johnson and AstraZeneca's COVID-19 vaccines have emerged in recent weeks, and U.S. health regulators April 13 recommended that the use of the Johnson & Johnson vaccine be halted while six blood-clotting cases are investigated.